HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY):
Reacting to certain statements that appeared in the media today relating to its corporate governance practices, Dr. Reddy’s spokesperson said “Dr. Reddy’s has always adhered to all disclosure requirements both of the Securities and Exchange Commission (SECs) and Indian Stock Exchanges; including accounting practices as per the International Financial Reporting Standards (IFRS) and the Indian Accounting Standards. The Company has no further comment on what might be advertorial Press releases by law firms and refutes all allegations.”
